Physician profile
Berit Walters
NPI 1245073808
$949.40
in general payments reported to CMS, 2019-2025
20 companies · $682 in 2025
The $682 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $267 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $164.82 | 2024-2025 | Fasenra, Airsupra, Farxiga |
| Sanofi-Aventis U.S. LLC | $115.54 | 2024-2025 | |
| Amgen INC. | $75.34 | 2025 | Repatha |
| Otsuka America Pharmaceutical, INC. | $71.73 | 2024-2025 | Rexulti |
| Abbvie INC. | $68.87 | 2024-2025 | |
| Boston Scientific Corporation | $58.39 | 2025 | Watchman Flx |
| Lilly USA, LLC | $51.04 | 2025 | Kisunla, Jardiance |
| Glaxosmithkline, LLC. | $42.27 | 2025 | Arexvy, Trelegy Ellipta |
| Pfizer INC. | $38.88 | 2025 | |
| Janssen Pharmaceuticals, INC | $38.26 | 2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $34.88 | 2025 | |
| Amneal Pharmaceuticals LLC | $34.48 | 2025 | Unithroid |
| Sumitomo Pharma America, INC. | $26.47 | 2024 | Gemtesa |
| Astellas Pharma US INC | $22.78 | 2025 | Veozah |
| Mimedx Group, INC. | $22.45 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $19.09 | 2025 | Recorlev |
| Gilead Sciences, INC. | $17.62 | 2024 | Epclusa |
| Viatris Specialty LLC | $16.81 | 2025 | Yupelri |
| Lundbeck LLC | $15.69 | 2025 | Rexulti |
| Exact Sciences Corporation | $13.99 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berit Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.